» Articles » PMID: 32410127

Medication to Manage Abortion and Miscarriage

Overview
Publisher Springer
Specialty General Medicine
Date 2020 May 16
PMID 32410127
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Abortion and miscarriage are common, affecting millions of US women each year. By age 45, one in four women in the USA will have had an abortion, and at least as many will have had a miscarriage. Most individuals seeking abortion services do so before 10 weeks' gestation when medication abortions are a safe and effective option, using a regimen of oral mifepristone followed by misoprostol tablets. When a pregnancy is non-viable before 13 weeks' gestation, it is referred to as an early pregnancy loss or miscarriage and can be managed using the same mifepristone and misoprostol regimen. Given their safety and efficacy, mifepristone and misoprostol can be offered in ambulatory settings without special equipment or on-site emergency services. As more patients find it difficult to access clinical care when faced with an undesired pregnancy or a miscarriage, it is important for general internists and primary care providers to become familiar with how to use medications to manage these common conditions. We summarize the most recent evidence regarding the use of mifepristone with misoprostol for early abortion and miscarriage. We discuss clinical considerations and resources for integrating mifepristone and misoprostol into clinical practice. By learning to prescribe mifepristone and misoprostol, clinicians can expand access to time-sensitive health services for vulnerable populations.

Citing Articles

[Clinical aspects of the preparation, performance, and follow-up of a first trimester abortion].

David M Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2024; 68(1):38-44.

PMID: 39625582 PMC: 11732934. DOI: 10.1007/s00103-024-03981-8.


High-risk factors for massive haemorrhage in medical abortion patients with missed miscarriage.

Tan Y, Li S, Xu H, Wang S BMC Pregnancy Childbirth. 2024; 24(1):521.

PMID: 39245736 PMC: 11382378. DOI: 10.1186/s12884-024-06682-x.


Medical management of first trimester missed miscarriages - A cross-sectional study.

Nasser S, Makhdoom T, Alhubaishi L, Elbiss H Pak J Med Sci. 2024; 40(7):1425-1429.

PMID: 39092024 PMC: 11255787. DOI: 10.12669/pjms.40.7.8751.


Delays in Obtaining Abortion and Miscarriage Care Among Pregnant Persons in New York State During the COVID-19 Pandemic: The CAP Study.

Pickering S, Manze M, Losch J, Romero D Womens Health Rep (New Rochelle). 2024; 5(1):30-39.

PMID: 38249936 PMC: 10797165. DOI: 10.1089/whr.2023.0128.


Structural basis of prostaglandin efflux by MRP4.

Pourmal S, Green E, Bajaj R, Chemmama I, Knudsen G, Gupta M Nat Struct Mol Biol. 2024; 31(4):621-632.

PMID: 38216659 PMC: 11145372. DOI: 10.1038/s41594-023-01176-4.


References
1.
Cameron S, Glasier A, Johnstone A, Dewart H, Campbell A . Can women determine the success of early medical termination of pregnancy themselves?. Contraception. 2014; 91(1):6-11. DOI: 10.1016/j.contraception.2014.09.009. View

2.
Biggs M, Ralph L, Raifman S, Foster D, Grossman D . Support for and interest in alternative models of medication abortion provision among a national probability sample of U.S. women. Contraception. 2018; 99(2):118-124. DOI: 10.1016/j.contraception.2018.10.007. View

3.
Raymond E, Harrison M, Weaver M . Efficacy of Misoprostol Alone for First-Trimester Medical Abortion: A Systematic Review. Obstet Gynecol. 2018; 133(1):137-147. PMC: 6309472. DOI: 10.1097/AOG.0000000000003017. View

4.
Upadhyay U, Desai S, Zlidar V, Weitz T, Grossman D, Anderson P . Incidence of emergency department visits and complications after abortion. Obstet Gynecol. 2015; 125(1):175-183. DOI: 10.1097/AOG.0000000000000603. View

5.
Cameron S, Glasier A, Dewart H, Johnstone A, Burnside A . Telephone follow-up and self-performed urine pregnancy testing after early medical abortion: a service evaluation. Contraception. 2012; 86(1):67-73. DOI: 10.1016/j.contraception.2011.11.010. View